Adam Brufsky, MD on HER2 Guidelines in Genomic Profiling: How Did Patients Do? #ASCO2020

Adam Brufsky, MD, PhD of University of Pittsburgh Cancer Institute discusses the MINDACT and HER2 guidelines in genomic profiling for breast cancer.

Read here: https://meetinglibrary.asco.org/record/188425/abstract